Immunogenicity 10916
Sample ID
3678
Response
Negative
Tumor Type
Melanoma
Gene Symbol
MKRN2
Transcript ID
None
HLA INFO
A*03:01
TCR INFO
No TCR info found!
Full length protein sequence (373 aa)
MSTKQ
1
ITCRY
6
DHTRP
11
SAAAG
16
GAVGT
21
MAHSV
26
PSPAF
31
HSPHP
36
PSEVT
41
ASIVK
46
TNSHE
51
PGKRE
56
KRTLV
61
LRDRN
66
LSGMA
71
ERKTQ
76
PSMVS
81
NPGSC
86
SDPQP
91
SPEMK
96
PHSYL
101
DAIRS
106
GLDDV
111
EASSS
116
YSNEQ
121
QLCPY
126
AAAGE
131
CRFGD
136
ACVYL
141
HGEVC
146
EICRL
151
QVLHP
156
FDPEQ
161
RKAHE
166
KICML
171
TFEHE
176
MEKAF
181
AFQAS
186
QDKVC
191
SICME
196
VILEK
201
ASASE
206
RRFGI
211
LSNCN
216
HTYCL
221
SCIRQ
226
WRCAK
231
QFENP
236
IIKSC
241
PECRV
246
ISEFV
251
IPSVY
256
WVEDQ
261
NKKNE
266
LIEAF
271
KQGMG
276
KKACK
281
YFEQG
286
KGTCP
291
FGSKC
296
LYRHA
301
YPDGR
306
LAEPE
311
KPRKQ
316
LSSQG
321
TVRFF
326
NSVRL
331
WDFIE
336
NRESR
341
HVPNN
346
EDVDM
351
TELGD
356
LFMHL
361
SGVES
366
SEP
371
Mutation Information
DNA mutation:
None
Peptide Range:
89 ~ 113
Mut AA position:
101 (13 in Wild Type peptide)
Alignment
Wild Type:
"SCSDPQPSPEMKPHSYLDAIRSGLD
||||||||||||.||||||||||||
Mutant:
SCSDPQPSPEMKSHSYLDAIRSGLD"
Clin Cancer Res, 2017
Isolation of T-Cell Receptors Specifically Reactive with Mutated Tumor-Associated Antigens from Tumor-Infiltrating Lymphocytes Based on CD137 ExpressionGene Name (from Reference) MKRN2
Checkpoint
Blockade
None
ACT
None
Vaccination
None
Curative
Effect
None
minimal_peptide
None
Antigen
Type
TMG RNA
T-cell
Source
TILs
APC
Type
autologous DCs
Assay
ELISPOT assay